Despite weathering significant criticism from lawmakers and patient groups over the steep cost of its rare disease med ...
Pratteln, Switzerland Tuesday, January 7, 2025, 11:00 Hrs [IST] ...
Santhera partners with Clinigen to supply Agamree for Duchenne muscular dystrophy in regions without commercial availability.
Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Clinigen Group to manage the supply and distribution of AGAMREE® (vamorolone) ...
4d
Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Clinigen Group to manage the supply and distribution of AGAMREE® (vamorolone) in countries where the product ...
Santhera Pharmaceuticals Holding AG (VTX:SANN) shareholders will doubtless be very grateful to see the share price up 43% in the last month. But that doesn't change the fact that the returns over ...
1 Day SANN 9.37% DJIA 0.91% Russell 2K 1.00% Health Care/Life Sciences 0.32% ...
Pratteln, Switzerland, December 20, 2024 – Santhera Pharmaceuticals (SIX: SANN) announces that the Department of Health of Hong Kong, China, has approved AGAMREE® (vamorolone) for use in patients aged ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback